AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...

By Ahmed Aboulenein and Maggie Fick WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

UK-based pharmaceutical giant AstraZeneca plans to build its largest drug manufacturing facility in Virginia, creating ...

The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several ...

Ahead of the 10-year anniversary of Tagrisso’s initial FDA approval this fall, AstraZeneca has debuted the first ...

British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030.

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...

RICHMOND, Va. (WDBJ) - Astrazeneca is deciding where in Virginia it will establish its newest multi-billion dollar ...

AstraZeneca PLC closed 20.27% below its 52-week high of £133.88, which the company reached on September 3rd.